LncRNA CRNDE binds hnRNPA1 to facilitate carbon monoxide poisoning-induced delayed encephalopathy via inhibiting UCHL5-mediated SMO deubiquitination

• Published in: Metabolic brain disease Vol. 38; no. 3; pp. 1097 - 1113
• Main Authors: Liu, Zuolong, Bian, Miao, Pang, Li
• Format: Journal Article
• Language: English
• Published: New York Springer US 01-03-2023; Springer Nature B.V
• Subjects: Animals; Apoptosis; Biochemistry; Biomedical and Life Sciences; Biomedicine; Brain; Brain Diseases - complications; Brain injury; Carbon; Carbon monoxide; Carbon monoxide poisoning; Carbon Monoxide Poisoning - complications; Complications; Deprivation; Encephalopathy; Gene expression; Head injuries; Hippocampus; Immunofluorescence; Immunoprecipitation; Inhalation; Intoxication; Metabolic Diseases; mRNA; N6-methyladenosine; Neurological diseases; Neurology; Neurosciences; Non-coding RNA; Oncology; Original Article; Oxygen; Poisoning; Rats; RNA, Long Noncoding - genetics; Staining; Therapeutic targets; Ubiquitination; DEACMP; Ubiquitination; hnRNPA1; CRNDE; UCHL5
• ISSN: 0885-7490; 1573-7365
• DOI: 10.1007/s11011-022-01157-4

Delayed encephalopathy after acute carbon monoxide poisoning (DEACMP) is one of the most common complications following carbon monoxide intoxication. Long noncoding RNAs (lncRNAs) exert critical functions in numerous neurological disorders. We intended to investigate the role of CRNDE in DEACMP. The DEACMP model in rats and the oxygen–glucose deprivation/reoxygenation (OGD/R) model in PC-12 cells were established. Brain and cell injuries were assessed with H&E staining, Nissl staining, TUNEL and CCK8 assays, respectively. Related proteins and RNAs were quantified with western blot and qRT-PCR. The N6-methyladenosine (m6A) level was determined using MeRIP-qPCR and immunofluorescence. Loss and gain function studies were performed to investigate the biological function of CRNDE. The potential mechanisms between each factor were explored using RNA immunoprecipitation, RNA-pull down and co-immunoprecipitation. CRNDE was increased in the hippocampal tissues of DEACMP rats and in OGD/R-treated PC-12 cells, which was positively correlated to m6A modification. Knockdown of CRNDE reduced cell damage and elevated UCHL5 and SMO expressions in OGD/R-treated PC-12 cells. hnRNPA1 was upregulated in DEACMP. In addition, inhibiting hnRNPA1 prevented apoptosis in PC-12 cells subjected to OGD/R. hnRNPA1 bound to CRNDE and remained in the nucleus, which inhibited UCHL5 expression through the formation of CRNDE-hnRNPA1-mRNA complex. UCHL5 could inhibit SMO ubiquitination and suppress PC-12 cell apoptosis during OGD/R. CRNDE silencing blocked brain injury in DEACMP, while knocking down UCHL5 reversed these effects. CRNDE interacted with hnRNPA1 to facilitate DEACMP via inhibition of UCHL5-mediated SMO deubiquitination. CRNDE might be a latent therapeutic target for treating DEACMP.